We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Loss of Hair Pigment Linked to Nervous System Disorders

By Biotechdaily staff writers
Posted on 12 Feb 2003
A study has found that mice with mutations that reduce the amount of hair pigment so that they have a mahogany appearance also suffer from nervous system disorders that resemble such diseases as bovine spongiform encephalopathy (BSE), Parkinson's, and Alzheimer's. More...
The findings were published in the January 31, 2003, issue of Science.

Investigators from Cornell University (Ithaca, NY, USA) and Stanford University (Stanford, CA, USA) genetically engineered a line of mice lacking the mahoganoid gene. These mice were similar in phenotype to mice lacking the Attractin (Atrn) gene. Attractin is a highly conserved integral membrane protein that functions in the maintenance of neural system architecture, immune cell interactions, and neuropeptide presentation regulating pigmentation.

The mahoganoid mice had brain malformations similar to those seen in cows with BSE. However, senior author Dr. Teresa M. Gunn, assistant professor of genetics in Cornell's College of Veterinary Medicine explained, "We do see the same kind of tissue degeneration -- with fluid-filled vacuoles, or holes, where the gray matter should be -- in BSE cattle with bovine spongiform encephalopathy and in these mutant mice. But the mice do not have the same motor coordination problems as mad cows, and the condition is not lethal.”

The authors concede that mahoganoid mice do not provide a model for the study of BSE, since prion particles are not involved. On the other hand, the mice could be valuable animal models for human disorders, such as Parkinson's and Alzheimer's disease.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.